The 1 analysts offering 12-month price forecasts for Brickell Biotech Inc have a median target of 12.60, with a high estimate of 12.60 and a low estimate of 12.60. The median estimate represents a +286.50% increase from the last price of 3.26.
The current consensus among 1 polled investment analysts is to Hold stock in Brickell Biotech Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.00
Reporting Date Mar 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.